a16z
a16z Bets on Stipple Bio's Precision Oncology Targeting
a16z backs Stipple Bio to solve on-target, off-tumor toxicity in cancer drugs using novel tumor biology.
Apr 62 min readopcnew Editoriala16z.news
1 article tagged with this topic
a16z backs Stipple Bio to solve on-target, off-tumor toxicity in cancer drugs using novel tumor biology.